Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason

NCT: NCT03492944 · COMPLETED

NCT IDNCT03492944
StatusCOMPLETED
Start Date2020-03-06
Completion2025-10-30
SponsorChildren's Hospital Medical Center, Cincinnati (OTHER)
First posted
Last updated

Brief Summary

The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease

Frequently Asked Questions

What is Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason?

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason is a clinical trial registered under NCT03492944. Current status: COMPLETED.

What is the status of NCT03492944?

The current status of NCT03492944 (Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason) is: COMPLETED.

When did Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason start?

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason started on 2020-03-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.